Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in anIn VitroPharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum

  • A. Elefanti, J. W. Mouton, P. E. Verweij, L. Zerva, J. Meletiadis
  • Antimicrobial Agents and Chemotherapy, February 2014, ASM Journals
  • DOI: 10.1128/aac.02661-13

The authors haven't yet claimed this publication.

Read Publication

In partnership with: